EcoDrugPlus

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSLBEG00000025401
Gene Symbol: APH1A
3 Cross references
190 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSLBEG00000010248
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSLBEG00000002043
Gene Symbol: ALOX12
1 Cross references
199 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSLBEG00000006762
Gene Symbol: ALOX5
3 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSLBEG00000002690
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSLBEG00000002197
Gene Symbol: LOC109976738
3 Cross references
199 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSLBEG00000022201
Gene Symbol: AVPR1A
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLBEG00000014893
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLBEG00000002537
Gene Symbol: AVPR2
2 Cross references
148 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSLBEG00000012718
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSLBEG00000027005
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSLBEG00000020691
Gene Symbol: LOC109985084
4 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).